Barclays PLC grew its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 43.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 62,563 shares of the company's stock after buying an additional 19,093 shares during the period. Barclays PLC owned approximately 0.35% of Addus HomeCare worth $7,842,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently modified their holdings of ADUS. American Century Companies Inc. boosted its stake in Addus HomeCare by 695.8% during the 4th quarter. American Century Companies Inc. now owns 284,346 shares of the company's stock worth $35,643,000 after acquiring an additional 248,613 shares during the last quarter. TimesSquare Capital Management LLC grew its holdings in shares of Addus HomeCare by 28.5% in the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock valued at $44,593,000 after buying an additional 78,835 shares during the period. Principal Financial Group Inc. increased its position in shares of Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock valued at $67,293,000 after buying an additional 75,409 shares in the last quarter. Pier Capital LLC bought a new position in Addus HomeCare during the fourth quarter worth about $8,406,000. Finally, Raymond James Financial Inc. acquired a new position in Addus HomeCare in the fourth quarter valued at about $6,637,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.
Addus HomeCare Trading Up 1.0 %
Shares of Addus HomeCare stock traded up $1.04 on Friday, reaching $100.58. 97,408 shares of the company were exchanged, compared to its average volume of 162,804. The company has a market capitalization of $1.83 billion, a price-to-earnings ratio of 23.02, a PEG ratio of 1.41 and a beta of 0.93. Addus HomeCare Co. has a one year low of $88.96 and a one year high of $136.72. The company has a 50-day moving average of $97.93 and a 200 day moving average of $116.06.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Analysts predict that Addus HomeCare Co. will post 4.59 earnings per share for the current year.
Analyst Ratings Changes
A number of equities research analysts have recently commented on ADUS shares. Macquarie reaffirmed an "outperform" rating and set a $129.00 price target on shares of Addus HomeCare in a research report on Thursday, February 27th. StockNews.com lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Oppenheimer increased their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Stephens reaffirmed an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a research report on Wednesday, March 12th. Finally, JMP Securities reiterated a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a report on Tuesday. One equities research analyst has rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $139.00.
View Our Latest Report on ADUS
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.